Triple Negative Breast Cancer (TNBC) as the most aggressive form of BC is characterized by a lack of estrogen receptor (ER), epidermal growth factor receptor 2 (HER-2), and progesterone receptor (PR) that results in the failure of targeted therapies in these patients [62]. Here, ESR1 is linked to breast cancer.